News
AbbVie's cancer TCE etentamig hits the mark in myeloma
AbbVie has reported positive results with CD3xBCMA bispecific etentamig in multiple myeloma, but can it break into a crowded market?
News
Hutchmed rises on $1.3bn KRAS licensing deal with GSK
GSK has paid Hutchmed $110m upfront for rights to a preclinical KRAS and EGFR-directed drug with potential in colorectal, pancreatic, and lung cancer.
News
Netcompany claims NHS contract to help digitise screening
Denmark's Netcompany has been awarded a five-year, £215m contract from NHS England to build the digital infrastructure for adult screening programmes.
News
Akeso's ivonescimab extends survival in PD-L1+ lung cancer
Akeso's PD-1xVEGF drug ivonescimab improves survival in another late-stage Chinese trial, ahead of a key international study readout later this year.
News
PMV cues up filing for first p53-directed cancer therapy
PMV is preparing to file for approval of its first-in-class oral p53 protein reactivator, rezatopopt, for ovarian cancer in the first quarter of 2027.
News
Views & Analysis
Deep Dive
Editor's Picks
Editor's Picks
